Records containing: Inflammatory Myopathies
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-02-25The Effect of Inspiratory Muscle Training on the Functional Status of Patients With Inflammatory Myopathy
-
CLINICAL_TRIALS study record update · 2025-12-03Interferon Signature in Cancer Patients Treated With Anti-CTLA-4 and Anti-PD-1/PD-L1 Therapies: A Multicenter, Prospective, Observational Cohort Study Comparing Cancer Patients and Non-Cancer Patients With Systemic Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2025-09-23Mass Spectrometry-based Immune Profiling in Peripheral Blood of Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2025-08-20A Single-center Clinical Study Evaluating the Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells(QH103) in Refractory Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2025-02-12Safety and Efficacy of Universal CAR-T Cells (UWD-CD19) Combined with Immunosuppressants in the Treatment of Refractory Autoimmune Diseases
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-02-11A Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Imvotamab in Adult Participants With Active, Refractory Moderate-Severe Idiopathic Inflammatory Myopathies
-
CLINICAL_TRIALS study record update · 2021-12-15Search for Diagnostic and Prognostic Biomarkers (Molecular Signatures) in Systemic Sclerosis and Inflammatory Myopathies by a Multi-OMIC Strategy Integrating a Single Cell Analysis Approach